Investors tracking high-growth, government-linked technology names frequently weigh LUNR and RCAT side by side. Both operate in emerging defense-adjacent and aerospace segments, both rely heavily on U.S. government contracts, and both have delivered triple-digit revenue growth while remaining unprofitable. This stock comparison is most relevant to growth-oriented traders and thematic investors evaluating relative performance, market positioning, and the durability of each company's catalysts. By examining recent price behavior, financial trends, and sector-specific developments, readers can better understand how these two names compare in the current market environment. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in the industry.
LUNR is Intuitive Machines, a Houston-based space infrastructure and services company that designs lunar landers, spacecraft, and communications networks for commercial, government, and national-security customers. In recent weeks, the stock has rebounded from deeply depressed levels following a prolonged drawdown from its 52-week high of $46.75. The catalyst was NASA's selection of the company for its next-generation Commercial Lunar Payload Services 2 (CLPS 2) program, a 10-year contract vehicle with a combined ceiling near $10 billion across eight awardees, potentially rising to $15 billion with an extension.
The company ended its latest reported quarter with a record backlog of roughly $1.8 billion and has reaffirmed full-year revenue guidance of $900 million to $1 billion. Recent third-quarter results beat analyst expectations on both revenue and earnings, reinforcing the view that contract wins are beginning to convert into sales. Still, the stock remains well below its peak, reflecting ongoing concerns about cash burn, margin execution, and its dependence on government procurement cycles.
RCAT is Red Cat Holdings, a provider of drone and robotic solutions for defense, national security, and commercial applications. Its portfolio includes the Black Widow small unmanned aircraft system and, through its Blue Ops unit, uncrewed surface vessels for maritime missions. The company has pursued an aggressive expansion strategy, including a tender offer for Steyr Motors and a strategic partnership with Sine Engineering on resilient communications and navigation.
Recent market activity has been challenging for the stock, which fell to a 52-week low of $3.25 in early November before stabilizing in the low-$4 range, far below its 52-week high of $18.78. Revenue has grown sharply, up 527% year over year in the latest reported quarter, but net losses have widened in tandem, and dilution risk from equity raises and acquisitions has weighed on sentiment. The company is scheduled to report third-quarter results shortly, leaving investors focused on whether scaling production can narrow losses.
While both companies serve government demand, their business models and growth drivers differ meaningfully. LUNR operates in space infrastructure, where revenue is anchored by a large, multi-year backlog and high-value NASA task orders that provide longer visibility but also concentrate risk in a single primary customer. RCAT operates in small tactical drones and maritime robotics, a segment with a broader customer base and a large addressable market but more fragmented, shorter-duration orders.
On scale, LUNR generates substantially higher revenue and holds a larger market capitalization, while RCAT is a smaller, earlier-stage operation with a faster headline growth rate but deeper relative losses. In terms of recent momentum, LUNR has shown a technical recovery above its 20-day moving average on contract news and an earnings beat, whereas RCAT has struggled below its short- and long-term moving averages after printing a new 52-week low. Both carry execution and policy risk, but the divergence in near-term catalysts and trend stability is the defining contrast in this stock comparison. From what I see, the technical picture favors the name with more stable momentum right now.
Based on observable factors including trend consistency, catalyst strength, and relative market positioning, Tickeron's AI framework would currently favor LUNR over RCAT. The aerospace name combines a record contracted backlog, a larger and faster-converting revenue base, a fresh high-visibility NASA award, and a recent earnings beat, all of which support a more stable technical posture. RCAT retains a credible long-term growth story, but its wider losses, fresh 52-week low, and pending dilution and acquisition uncertainty suggest less favorable near-term positioning. This assessment is probabilistic and reflects current data rather than a definitive prediction. I’m watching this closely as the earnings season unfolds.
In my own research process, I’ve found value in turning to Tickeron’s AI Trading Bots when comparing names like these. The platform offers a range of automated strategies that run across thousands of tickers, allowing users to observe how data-driven models interpret momentum, positioning, and risk in real time. It serves as a useful complement to traditional fundamental work, especially when evaluating relative strength between two volatile growth stocks.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where RCAT advanced for three days, in 233 of 260 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RCAT's RSI Oscillator exited the oversold zone, 16 of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 62 cases where RCAT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for RCAT just turned positive on November 06, 2026. Looking at past instances where RCAT's MACD turned positive, the stock continued to rise in 34 of 41 cases over the following month. The odds of a continued upward trend are 83%.
RCAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RCAT as a result. In 69 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for RCAT entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.309) is normal, around the industry mean (5.050). P/E Ratio (-5.050) is within average values for comparable stocks, (17.247). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (11.820) is also within normal values, averaging (18.367).
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. RCAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 91 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AerospaceDefense